Overexpression of STOML1 is associated with good prognosis in nasopharyngeal carcinoma

  • 0Department of Radiotherapy I, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi 530021, P.R. China.

|

|

Summary

This summary is machine-generated.

This study identifies stomatin like 1 (STOML1) as a key prognostic biomarker for nasopharyngeal carcinoma (NPC). High STOML1 expression correlates with improved survival, offering potential for better NPC diagnosis and prognosis.

Area Of Science

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background

  • Nasopharyngeal carcinoma (NPC) is a challenging head and neck cancer with a high recurrence rate.
  • Identifying reliable prognostic markers is crucial for improving patient outcomes in NPC.

Purpose Of The Study

  • To identify key genes and molecular mechanisms influencing NPC prognosis.
  • To evaluate the potential of identified genes as diagnostic and prognostic biomarkers for NPC.

Main Methods

  • Utilized DNA microarray and cDNA profiling to analyze gene expression in NPC patients.
  • Employed bioinformatics, immunohistochemistry, and Cox regression analysis for prognostic factor identification.
  • Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses to elucidate mechanisms.

Main Results

  • Six genes, including stomatin like 1 (STOML1), were identified as significant prognostic factors.
  • High STOML1 mRNA and protein expression correlated significantly with improved overall survival (OS) and disease-free survival (DFS) in NPC.
  • Combining STOML1 expression with TNM staging improved the predictive accuracy for 5-year OS.

Conclusions

  • STOML1 plays a critical role in NPC progression and serves as a valuable independent prognostic biomarker.
  • STOML1 holds potential for enhancing NPC diagnosis and predicting patient prognosis.
  • Identified genes are primarily involved in apoptosis and cancer progression pathways.